286 related articles for article (PubMed ID: 28115355)
1. Synergistic Interactions of MmpL3 Inhibitors with Antitubercular Compounds
Li W; Sanchez-Hidalgo A; Jones V; de Moura VC; North EJ; Jackson M
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115355
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3.
Li W; Obregón-Henao A; Wallach JB; North EJ; Lee RE; Gonzalez-Juarrero M; Schnappinger D; Jackson M
Antimicrob Agents Chemother; 2016 Sep; 60(9):5198-207. PubMed ID: 27297488
[TBL] [Abstract][Full Text] [Related]
3. A piperidinol-containing molecule is active against
Dupont C; Chen Y; Xu Z; Roquet-Banères F; Blaise M; Witt AK; Dubar F; Biot C; Guérardel Y; Maurer FP; Chng SS; Kremer L
J Biol Chem; 2019 Nov; 294(46):17512-17523. PubMed ID: 31562241
[No Abstract] [Full Text] [Related]
4. Novel insights into the mechanism of inhibition of MmpL3, a target of multiple pharmacophores in Mycobacterium tuberculosis.
Li W; Upadhyay A; Fontes FL; North EJ; Wang Y; Crans DC; Grzegorzewicz AE; Jones V; Franzblau SG; Lee RE; Crick DC; Jackson M
Antimicrob Agents Chemother; 2014 Nov; 58(11):6413-23. PubMed ID: 25136022
[TBL] [Abstract][Full Text] [Related]
5. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862
[TBL] [Abstract][Full Text] [Related]
6. MmpL3 inhibitors as antituberculosis drugs.
Shao M; McNeil M; Cook GM; Lu X
Eur J Med Chem; 2020 Aug; 200():112390. PubMed ID: 32447196
[TBL] [Abstract][Full Text] [Related]
7. 1
Korycka-Machała M; Viljoen A; Pawełczyk J; Borówka P; Dziadek B; Gobis K; Brzostek A; Kawka M; Blaise M; Strapagiel D; Kremer L; Dziadek J
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332069
[TBL] [Abstract][Full Text] [Related]
8. HC2091 Kills Mycobacterium tuberculosis by Targeting the MmpL3 Mycolic Acid Transporter.
Zheng H; Williams JT; Coulson GB; Haiderer ER; Abramovitch RB
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29661875
[TBL] [Abstract][Full Text] [Related]
9. Clofazimine Exposure
Ismail N; Peters RPH; Ismail NA; Omar SV
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642938
[TBL] [Abstract][Full Text] [Related]
10. No in vitro synergistic effect of bedaquiline combined with fluoroquinolones, linezolid, and clofazimine against extensively drug-resistant tuberculosis.
Pang Y; Jing W; Lu J; Zong Z; Huo F; Dong L; Dai G; Li Y; Huang H; Chu N
Diagn Microbiol Infect Dis; 2019 Aug; 94(4):361-364. PubMed ID: 30876684
[TBL] [Abstract][Full Text] [Related]
11. Structure-Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis.
Belardinelli JM; Yazidi A; Yang L; Fabre L; Li W; Jacques B; Angala SK; Rouiller I; Zgurskaya HI; Sygusch J; Jackson M
ACS Infect Dis; 2016 Oct; 2(10):702-713. PubMed ID: 27737557
[TBL] [Abstract][Full Text] [Related]
12. A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
Ruth MM; Sangen JJN; Remmers K; Pennings LJ; Svensson E; Aarnoutse RE; Zweijpfenning SMH; Hoefsloot W; Kuipers S; Magis-Escurra C; Wertheim HFL; van Ingen J
J Antimicrob Chemother; 2019 Apr; 74(4):935-943. PubMed ID: 30649327
[TBL] [Abstract][Full Text] [Related]
13. Altered drug efflux under iron deprivation unveils abrogated MmpL3 driven mycolic acid transport and fluidity in mycobacteria.
Pal R; Hameed S; Fatima Z
Biometals; 2019 Feb; 32(1):49-63. PubMed ID: 30430296
[TBL] [Abstract][Full Text] [Related]
14. Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria.
Fay A; Czudnochowski N; Rock JM; Johnson JR; Krogan NJ; Rosenberg O; Glickman MS
mBio; 2019 Jun; 10(3):. PubMed ID: 31239378
[TBL] [Abstract][Full Text] [Related]
15. Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in
Grover S; Engelhart CA; Pérez-Herrán E; Li W; Abrahams KA; Papavinasasundaram K; Bean JM; Sassetti CM; Mendoza-Losana A; Besra GS; Jackson M; Schnappinger D
ACS Infect Dis; 2021 Jan; 7(1):141-152. PubMed ID: 33319550
[TBL] [Abstract][Full Text] [Related]
16. Direct Inhibition of MmpL3 by Novel Antitubercular Compounds.
Li W; Stevens CM; Pandya AN; Darzynkiewicz Z; Bhattarai P; Tong W; Gonzalez-Juarrero M; North EJ; Zgurskaya HI; Jackson M
ACS Infect Dis; 2019 Jun; 5(6):1001-1012. PubMed ID: 30882198
[TBL] [Abstract][Full Text] [Related]
17. Primary Clofazimine and Bedaquiline Resistance among Isolates from Patients with Multidrug-Resistant Tuberculosis.
Xu J; Wang B; Hu M; Huo F; Guo S; Jing W; Nuermberger E; Lu Y
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320727
[TBL] [Abstract][Full Text] [Related]
18. Structure-based design of anti-mycobacterial drug leads that target the mycolic acid transporter MmpL3.
Hu T; Yang X; Liu F; Sun S; Xiong Z; Liang J; Yang X; Wang H; Yang X; Guddat LW; Yang H; Rao Z; Zhang B
Structure; 2022 Oct; 30(10):1395-1402.e4. PubMed ID: 35981536
[TBL] [Abstract][Full Text] [Related]
19. Cross-resistance between clofazimine and bedaquiline through upregulation of MmpL5 in Mycobacterium tuberculosis.
Hartkoorn RC; Uplekar S; Cole ST
Antimicrob Agents Chemother; 2014 May; 58(5):2979-81. PubMed ID: 24590481
[TBL] [Abstract][Full Text] [Related]
20. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis.
Tahlan K; Wilson R; Kastrinsky DB; Arora K; Nair V; Fischer E; Barnes SW; Walker JR; Alland D; Barry CE; Boshoff HI
Antimicrob Agents Chemother; 2012 Apr; 56(4):1797-809. PubMed ID: 22252828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
